Statement on malignant mesothelioma in the United Kingdom
about
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesotheliomaPemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesotheliomaPrimary Peritoneal Mesothelioma Resulting in Small Bowel Obstruction: A Case Report and Review of LiteratureBTS statement on malignant mesothelioma in the UK, 2007.Malignant pleural mesothelioma: a single-center experience in Turkey.Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?Current chemotherapeutic treatment of malignant pleural mesothelioma.Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma.Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialMalignant pleural mesothelioma: update on treatment options with a focus on novel therapies.Emerging drugs for mesothelioma.Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesotheliomaUsefulness of the Japanese Respiratory Society guidelines for community pneumonia: a retrospective analysis of community-acquired pneumonia between 2000 and 2002 in a general hospital.Addition of macrolide in treating adult hospitalized community-acquired pneumonia.Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.Radical surgery for mesothelioma.The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia.Antibiotic prescribing.Malignant mesothelioma: Canadian perspective and research directions.The Prevalence of Oropharyngeal Dysphagia in Danish Patients Hospitalised with Community-Acquired Pneumonia.Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia.Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool.
P2860
Q24243222-C74EFAB8-4425-488B-8F3F-6A8ECB253C17Q24245306-442CAACA-913B-4A01-915F-A03F4718761FQ26801782-9C129FF0-D54A-4771-A382-15EE0BD250C6Q30478994-7A72424F-7718-47DB-82B5-B5B6B0A22EB6Q33686248-4651B824-1BE5-4741-9EC8-EB9E511A7941Q35129655-21112645-9950-4F88-A02B-3E0557C53505Q35967314-FE7B9C2B-A656-4C16-BD33-9FFCCDAB21FCQ36162505-B9ABA66A-C04E-4ABB-A800-26B06F31F4A4Q36526737-96CD659C-25EC-4903-8AC5-BAEBFD8E1FF1Q36625951-B03777A6-F0A5-4206-9CF0-C8E8AFDD8935Q36727434-B06D55BA-0F0B-4872-A869-B3ACA0FD289AQ36728254-1C32522D-1E72-4387-8A98-085FB613AFE3Q36758593-0A9B6FC9-46A4-4686-9A0F-2EF8456ADBE9Q36822893-95F52AEC-F66F-434A-9E89-438DD0685C00Q39713119-A1662B72-9819-407A-B460-C0494E5ECC8FQ39720406-B84B4F72-06B9-4C09-BA87-96BA9A600284Q39836338-68FA66B8-F741-4C54-B2E3-62F696EDD3FEQ42745414-A4BDE602-1A44-493B-9935-9A6319BB276AQ45236144-ABCD4592-BFD8-4C3A-95F0-B9CE4DA28E1CQ46333168-9AEB696D-EB50-4D6A-B1B0-45DE84D29515Q47098675-B12EEFAF-45D3-497B-947B-BE647C6A1988Q48014196-6FCE91E3-6431-4912-B6BE-BA2D04A63CE5Q51042330-4752B501-13D7-42CF-94A4-6953B38D7D58Q53028451-2F654EC0-0077-40E0-8C3A-12DB774BF0D2
P2860
Statement on malignant mesothelioma in the United Kingdom
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Statement on malignant mesothelioma in the United Kingdom
@ast
Statement on malignant mesothelioma in the United Kingdom
@en
type
label
Statement on malignant mesothelioma in the United Kingdom
@ast
Statement on malignant mesothelioma in the United Kingdom
@en
prefLabel
Statement on malignant mesothelioma in the United Kingdom
@ast
Statement on malignant mesothelioma in the United Kingdom
@en
P2860
P356
P1433
P1476
Statement on malignant mesothelioma in the United Kingdom
@en
P2093
British Thoracic Society Standards of Care Committee
P2860
P304
P356
10.1136/THORAX.56.4.250
P407
P577
2001-04-01T00:00:00Z